Introduction
Recommendations on how to break a bad news diagnosis are generally based on empirical evidence (often scant) and expert opinion [1] [2] [3] . A few studies [4] [5] [6] [7] [8] have sought to provide patient-based evidence for these recommendations rather than relying on clinical opinion. However, these studies have focused on a limited number of communication factors that relate to the disclosure of diagnosis but often not to the discussion of prognosis and treatment that generally ensues.
Comprehensive guidelines on how to break bad news have been developed in Australia [9] . They cover almost all areas mentioned in the literature and their development was based on the consensus of relevant parties, namely patients, doctors and nurses. Acceptability and appropriateness of these guidelines have been investigated in a recent study [10] . Over 70% of patients rated all but a couple of the recommendations as 'essential'. Doctors' and nurses' ratings displayed far greater variability, but generally they endorsed most recommendations. While these results support the guidelines, they also raise concerns about the sensitivity of the scale when used by patients, especially in light of the modest patient response rate (51%). Also, a number of recommendations comprised two (or more) elements such as 'Tell the patient the diagnosis and prognosis honestly...'. It is conceivable that people may generally agree that it is 'essential' to be told their diagnosis but not 'essential' to be told their prognosis.
Another recent study described the communication experiences of breast cancer and melanoma patients and their preferences about diagnosis, prognosis and treatment [11] . However, patients reported on communication recollections three to four years post-diagnosis at which time memories of the consultation may have faded. There was also a possible sampling bias, as only the patients who had survived for this time period were included. It may be that their relatively good prognosis favourably coloured recall of the diagnosis consultation. More detailed information from patients is required to endorse, modify or extend the current Australian 'breaking bad news'guidelines and to identify discrepancies between patient preferences and their current experiences.
The present study was designed to advance previous work by eliciting detailed patient recollections of doctorpatient communication and preferences within three to four months of a cancer diagnosis. We used an extensive but simply worded set of communication characteristics, each containing a single concept, which approximated the Australian guidelines [9] . Melanoma patients were used in this study because melanoma is a highly prevalent, aggressive cancer in Australia [12] . The aims of the study were first, to explore patient preferences for how their diagnosis, its implications and treatment options should be communicated to them. Second, to document melanoma patients' recollections of hearing their diagnosis, prognosis and treatment options. And third, to identify any disparities between the current Australian guidelines for breaking bad news, and patient preferences and recollections.
Patients and methods

Setting
The setting of this study was the Sydney Melanoma Unit (SMU) at the Royal Prince Alfred Hospital. The SMU is a specialised, tertiary referral unit with a well established reputation for melanoma treatment.
Sample
A consecutive sample of 194 new patients with recently diagnosed melanoma attending the SMU for treatment or clinical opinion from one of five surgeons was studied. Patient inclusion criteria were: 1) a primary melanoma with a Breslow thickness of greater than 1.5 mm; 2) over 18 years of age; 3) English speaking; 4) contactable by telephone; and 5) no psychiatric disorder or serious cognitive impairment. Nine patients were recommended for exclusion by their treating surgeon because they were thought to be unable to cope with the demands of the study. Of the 150 patients who were selected, three had died prior to initial contact and 14 refused to participate. Characteristics of the 14 patients who refused to participate, including age, gender, site and depth of melanoma, were compared with those patients who responded. Patients who refused were significantly more likely to be female (chi-square: 4.90, P = 0.03). No other differences were noted. The remaining 133 patients completed the questionnaire, however two patients were lost because of administrative difficulties, giving a final sample of 131 (87% of the original sample). Table 1 presents demographic and disease characteristics of these patients.
Design and procedure
Patients were approached via a letter signed by their surgeon or by a researcher (LJB) one to two months after their initial consultation at the SMU asking them to participate and to complete a standardised hospital consent form. Patients were then telephoned to obtain verbal consent. Consenting patients were posted the questionnaire with a request that it be completed at home and returned by mail. The mean interval from the initial consultation at the SMU to questionnaire completion was 3.8 months (range: 1-9). Follow-up telephone calls 
Instrument
The questionnaire was adapted from one used in a previous study of communication in breast cancer and melanoma patients [11] ; additional items covered areas found to be important from focus groups and a literature review. The questionnaire asked patients to recall the time when they were first told that they had cancer. 
± 1.84 1.5-12.0 least important from a 'checklist' of 32 items covering diagnosis, treatment options, prognosis and other issues. This method of eliciting preferences was selected to produce greater spread in the data than a rating scale.
Patients' medical records provided information about demographics and disease characteristics, specifically melanoma depth, site and disease stage. Table 2 presents frequency distributions for patients' information and social support preferences.
Results
Patient information preferences
Diagnosis
Patients were asked how much information about the diagnosis they wanted at that time and how much they were given. The great majority wanted 'everything' (69%) and most of the remainder wanted 'a moderate amount' (26%).
Prognosis
Most patients (61%) wanted 'to know how the cancer would affect (their) life expectancy'. Discussion about the kinds of effects the patient's diagnosis of cancer 'would have on other aspects of life such as work and family life' was desired by 62% of patients.
Treatment
Patients were asked how much information they wanted about the treatment for their cancer. The vast majority wanted 'everything' (81%) and most of the remainder wanted 'a moderate amount' (16%). Patients were also asked when they considered it was best to talk about treatment decisions. Most patients responded 'immediately' (63%) after being told the diagnosis, 16% responded 'delay' the discussions until later and 22% responded 'both times'.
Supplementary information
The majority of patients (63%) reported that they would like supplementary written information about their diagnosis, but only 23% of patients would have liked supplementary information in the form of an audiotape. Three-quarters of the sample would have liked to receive a sheet listing questions often asked by cancer patients and 13% would have liked an audio taped recording of the consultation.
Patient social support preferences
Patients were asked to indicate who else they wanted to be present at the time they were told their diagnosis. Almost half (47%) wanted no one else present and 44% wanted their spouse present. Very few people wanted anyone other than their spouse present. Only one person wanted another medical physician present. No one said that they wanted a nurse or social worker present. Most patients (73%) endorsed the option of talking to a counsellor about feelings regarding cancer at some time after diagnosis. When asked to choose a number of preferred times for counselling, 16% of patients said 'straight after hearing the diagnosis'; 27% said 'at some stage, it is unpredictable'; 21% said 'a few days after diagnosis'and 16% said 'on more than one occasion'.
Patients' rating of the most important and least important communication strategies
Patients were asked to nominate the five most important and the five least important communication strategies for a doctor delivering and discussing a diagnosis of melanoma. If equal numbers of patients nominated each communication characteristic, then each would receive the support of about 20 patients or 15%. A clear majority of patients (62%) nominated 'being told the diagnosis face-to-face' as most important and nearly half (48%) rated 'feeling confident in getting the best treatment'. Other features thought to be 'most impor-tant' by at least one quarter of the sample were: 'no delays in confirming the diagnosis' (41%); 'being told the diagnosis in a private place' (39%); 'being told the diagnosis by a familiar doctor' (32%); 'the doctor using the word "cancer" directly' (32%); 'having plenty of opportunity to ask questions after the diagnosis' (28%); 'being presented with all available treatment options' (27%); 'getting all possible information about cancer' (26%); 'the doctor giving support' (26%) and 'having who you want present to hear the diagnosis' (25%).
The feature rated 'least important' by the most patients was 'doctor giving extra taped information' (65%), followed closely by 'getting a tape of the consultation' (60%). Features also considered 'least important' by at least a quarter of patients (more than 25%) were: 'the quality of the physical surroundings when giving the diagnosis' (55%); 'the doctor helping to tell others about the diagnosis' (41%); and 'the doctor giving a referral to a counsellor' (32%).
Patients' recollections of consultations Diagnosis
In 29% of consultations, the word 'cancer' was used to describe their diagnosis. Melanoma (65%) and malignant melanoma (27%) were the most frequently used alternatives. However, written comments by the patients indicated that all but six patients knew that the alternative terms meant cancer.
Most people reported being told their diagnosis by their general practitioner (48%), others by their surgeon (21%), cancer specialist' (18%) or other specialist, usually a dermatologist (9%). It was not uncommon for people to be told their diagnosis over the telephone (32%). Most patients (78%) were told their diagnosis in a private room (including the patient's home).
Patients were asked to indicate who else was present at the time they were told their diagnosis. In over half the cases (51%), there was no one else present with the patient when the diagnosis was disclosed. Their spouse was present in 30% of cases; another relative in 12% of cases and for a few people there was either a nurse or another doctor present. For 51% of patients, their preferences for whom they wanted present and their recollections of who was present matched.
The time from seeking help to confirmation of the diagnosis was perceived as 'far too long' or 'a bit too long' by 33% of the patients, however the majority (66%) said that the time interval was 'about right'.
Just over half the patients reported receiving the amount of information they wanted at diagnosis; though 37% received less information than they wanted and seven patients (5%) indicated they received more information than they would have liked. Although many patients wanted supplementary information, only 23% of patients received written supplementary information and only two people (1.5%) received taped supplementary information.
Prognosis
In contrast to the high proportions that wanted these discussions, 28% of patients recalled discussing life expectancy with their doctor and 25% recalled discussing how the diagnosis would affect other aspects of life such as work and family life.
Treatment
Eighty-six per cent of patients believed that they had been 'presented with all the available treatment options'. Thirty per cent of patients reported being presented with a choice of treatments. When asked to nominate all people who had a major part in making the final decision regarding treatment, 55% of patients said their cancer specialist; 53% said themselves; 37% said their surgeon; 18% said their spouse/partner; and 5% said a relative. The vast majority of patients (90%) were satisfied with their level of involvement in treatment decision-making.
Comparing the amount of information people wanted about treatment and the amount they received, 34% reported receiving less than they wanted; and only 6% received more than they wanted.
Psychosocial issues
Only a small proportion of patients (6%) reported that the doctor told them about cancer support services, and only 4% actually used any support services. Table 3 provides a comparison between items adapted from Australian 'breaking bad news' guidelines [9] and the preferences and recollections of melanoma patients. Almost all of the communication features listed were nominated by at least one quarter of the sample as 'important'. However, one characteristic, 'feeling confident in getting the best treatment', which was endorsed as 'most important' by nearly half the sample, did not appear in the recommendations. Two recommendations of the guidelines that did not receive endorsement as important in communication were 'the doctor helping tell others of the diagnosis'and 'telling the patient about cancer support services'.
Comparison of communication guidelines, patient preferences and their recollections of the consultations
A majority of patients reported that at least half of the 18 communication recommendations in the guidelines had occurred in their diagnosis consultation. Most notably, these included telling the diagnosis face-toface; and in private; discussing all treatment options; giving all information to patients about the cancer diagnosis; and the doctor being supportive and hopeful or reassuring. They were all rated as 'most important' by a substantial group of respondents. The recommendations that patients reported as occurring less frequently in the consultations, yet were assigned relatively high importance ratings were: 'use of the word "cancer" directly'; 'no delay in telling diagnosis'; and 'opportunities for questions after diagnosis'. 
Discussion
Current recommendations in Australia on 'how to break bad news' [9, 11] were largely supported by the preferences expressed by patients in this study. However, the results suggest that some modifications to the guidelines may be useful. Guidelines concerning communication at the time of diagnosis also need to incorporate recommendations related to discussions concerning treatment decisions. Patients rated 'feeling confident that they are getting the best treatment' as the second most important feature of communication. This may provide a constructive framework to allow patients to cope better with the bad news. Talking about treatment, or what can be done next, could be considered the good news antidote to the bad news of the diagnosis and its implications. Discussing treatment may restore a patient's sense of control in the face of the uncertainty that comes with learning about a potentially life threatening illness.
Social support issues, such as the doctor helping tell the diagnosis to others, information about cancer support services, or referral to a counsellor did not rank amongst the most important recommendations nominated by patients. However, given the choice, a high proportion of patients endorsed these practices. The recommendation that the doctor should arrange for another health professional to be present during a diagnosis consultation did not receive support from patients. Similar findings have been obtained in previous work [10, 11] . The desirability of having another health professional present finds little support amongst doctors either [10] . Further evidence is required to demonstrate that this recommendation provides any benefit to the patient.
Many patients reported that their experiences matched their expressed preferences and the recommended guidelines, however there were a few notable gaps. The majority of patients reported that the doctor had used the word 'melanoma' or 'malignant melanoma' instead of 'cancer'. As most patients knew that this meant cancer, melanoma is probably a special case. Nevertheless, as one third of the sample thought it was most important that the doctor use the word 'cancer', it reinforces the guideline's recommendation that doctors consciously try to speak in simple, colloquial language and avoid technical words.
About two-thirds of the patients reported experiencing a delay between first seeking medical advice and being told the diagnosis. Practical constraints mean that short delays in providing a diagnosis are unavoidable. Pathological analysis of the excised, suspicious lesion is a procedure that can take several days. However, the reported delays may result from difficulties that can be ameliorated. As this was endorsed as an important issue, future research could explore how long was 'too long'and ascertain the reasons for the delays.
Patients clearly prefer to be told their diagnosis faceto-face. In this study of melanoma patients, about one third reported receiving their diagnosis over the telephone and half of these patients expressed a preference to be told face-to-face. However, it can be very stressful for patients to wait for an available appointment, perhaps anticipating a 'bad news'diagnosis, and most melanoma patients are well prepared for the possibility of their diagnosis, in contrast to other types of cancer where the diagnosis can be an incidental discovery. Patients could be given the choice of having a face-to-face consultation when both doctor and patient can attend or for their doctor to provide their diagnosis over the telephone as soon as the pathology report comes through to reduce delays and alleviate the uncertainty of not knowing. In cases where the diagnosis is given over the telephone, it may be desirable for the doctor to set aside a period of uninterrupted time to make the phone call and then follow up shortly afterwards with an appointment.
One third of patients reported receiving less information than they desired about both diagnosis and treatment options. This is an important issue and every effort should be made to prompt questions from patients and allow sufficient time for discussion. If possible, the doctor should continue to prompt questions until the patient feels they have received 'everything' they wish to know and indicates that they have no more questions at that time. However, practical constraints may make it impossible for doctors to fulfil the expectations of a few patients who may desire very lengthy discussions. With respect to treatment options, it should also be noted that the treatment for melanoma is very different from most other cancers. At present, the best practice treatment of a primary melanoma involves a wide surgical excision of the lesion and no other options have been demonstrated to be beneficial. For metastatic disease, a possible treatment option is no treatment. By contrast, for breast cancer there are several options even for localised disease. Patients in this study reporting that treatment options were discussed with them would have been referring to either a clinical trial of sentinel lymph node biopsy or the possibility of elective lymph node dissection. The latter option ceased to be offered part way through this study because evidence became available suggesting that it provided little benefit for the patient.
There are different ways of helping time-pressured doctors to answer patients' questions. Three quarters (76%) of the patients supported the provision of a sheet or brochure with sample questions commonly asked by patients facing a diagnosis of melanoma. Previous research has shown that provision of a question prompt sheet helps to crystallize specific concerns for the patients and assists them in formulating and asking questions in consultations [13] . Active pursuit of information has been shown to be associated with better psychological adjustment [14] . Giving patients supplementary written information relating to their illness was also a popular suggestion and some patients also supported the option of receiving taped supplementary information or a tape of the consultation. The SMU has a 'Questions and Answers' brochure, which around a quarter of patients reported receiving. These patientpreferred procedures would be worthwhile additions to routine clinical practice that could assist clinicians in delivering the information their patients desire.
There are some limitations to the study that should be noted. First, it was limited to melanoma patients. However, this complements existing research in which female, breast cancer patients have been disproportionably represented [5, 7, 10, 11] . Second, while the list of communication recommendations studied in this paper was extensive, it was not exhaustive. Girgis et al. [10] included a number of recommendations that were not included in the present study. These recommendations covered the following issues: avoiding conspiracies of silence with the patient's relatives; being sensitive to the patient's cultural or social background; employing a trained health interpreter if necessary; checking the patient's understanding of the situation; encouraging the patient to express his/her feelings; and documenting what the patient has been told. All these communication recommendations received a high level of support from patients and doctors [10] . Third, it is acknowledged that patient recollections of what actually occurred in their consultations may be inaccurate. However, these data were collected three to four months after diagnosis. At this time, information about the extent of the disease and treatment options would have been disclosed and the high initial anxiety generated by the diagnosis dissipated [12] , while recall would still have been vivid owing to the 'flashbulb' effect that enhances memory of significant events [13] . Future research could utilise audio or video tape-recording of consultations to enhance objectivity.
This study provides overall support for the current Australian guidelines on 'breaking bad news' [9] . Three amendments to the guidelines are recommended. First, promoting patient confidence that they will receive the best possible treatment should be included. Second, since there was only weak support for the recommendations that the doctor ^should offer the patient help in telling others of the diagnosis, or should tell the patient of cancer support services, we believe these recommendations should become non-essential elements of the consultation. If the need arises, these offers of help could be made to patients on a discretionary basis. Third, the recommendation that another health professional should be present during the consultation should be removed, as there was no support for maintaining it. The results of the study also highlight the fact that patients with different types of cancers may require different approaches to achieve effective communication. Generic guidelines may be a valuable platform for the development of recommendations that are specific to patients with each common type of cancer. Finally, asking patients their preferences and identifying gaps between preferences and experiences is a first step towards achieving optimal doctor-patient communication. The next important step is to examine whether meeting patient expectations about communication actually improves patient outcomes.
